← Back to headlines
Immunic Appoints Mike Bonney as Board Chair Ahead of MS Trial
Immunic, a biopharmaceutical company, has appointed Mike Bonney, a veteran from Biogen and Cubist, as its new board chair. The appointment comes ahead of a key multiple sclerosis (MS) trial readout.
19 May, 13:33 — 19 May, 13:33
Sources
Showing 1 of 1 sources
Related Stories
Extreme Training: What Heat Training Does to the Body
just now
Police to enforce monthly environmental sanitation in Borno to fight cholera
just now
Oral Inflammation Linked to Reduced Fertility in New Israeli Study
6m ago
Air pollution and extreme heat linked to more migraine attacks, Israeli study finds
7m ago